Literature DB >> 7640202

Carney complex: the complex of myxomas, spotty pigmentation, endocrine overactivity, and schwannomas.

J A Carney1.   

Abstract

The complex of myxomas, spotty pigmentation, endocrine overactivity, and schwannomas (the Carney complex) is a multisystem tumorous disorder that is transmitted as a mendelian autosomal dominant trait. Approximately 150 affected patients are known worldwide. The myxomas, which tend to be multiple in the involved organ, affect the heart, skin and breast. Typical sites for the skin myxomas are the eyelids, external ear canal, and nipples. The lesions commonly recur after excision. The spotty skin pigmentation includes lentigines and blue nevi, but ephelides and junctional and compound nevi also occur. The lentigines are widespread and typically involve the centrofacial area, including the vermilion border of the lips, and the conjunctiva, especially the lacrimal caruncle and the conjunctival semilunar fold. One or more intraoral pigmented spots are seen occasionally. The blue nevi occur on the face, trunk, and limbs, but not the hands and feet. Endocrine overactivity includes Cushing's syndrome (caused by primary pigmented nodular adrenocortical disease), acromegaly (caused by growth hormone-producing pituitary adenoma), and sexual precocity (caused by large-cell calcifying Sertoli cell tumor). The schwannomas are a special histological type, featuring psammoma bodies and melanin. Most commonly, they affect the upper gastrointestinal tract and sympathetic nerve chains, but a few have occurred in the skin. The most serious component of the Carney complex is cardiac myxoma. Patients suspected of having the syndrome (and their primary relatives) should be examined for this neoplasm.

Entities:  

Mesh:

Year:  1995        PMID: 7640202     DOI: 10.1016/s1085-5629(05)80003-3

Source DB:  PubMed          Journal:  Semin Dermatol        ISSN: 0278-145X


  36 in total

Review 1.  PRKAR1A and the evolution of pituitary tumors.

Authors:  Lawrence S Kirschner
Journal:  Mol Cell Endocrinol       Date:  2010-05-06       Impact factor: 4.102

2.  A novel splice site mutation of the PRKAR1A gene, C.440+5 G>C, in a Chinese family with Carney complex.

Authors:  J Fu; F Lai; Y Chen; X Wan; G Wei; Y Li; H Xiao; X Cao
Journal:  J Endocrinol Invest       Date:  2018-01-09       Impact factor: 4.256

3.  Blue nevus of the nasal mucosa.

Authors:  Simonetta Piana; Silvia Asioli
Journal:  Virchows Arch       Date:  2005-01-25       Impact factor: 4.064

4.  Mutations and polymorphisms in the gene encoding regulatory subunit type 1-alpha of protein kinase A (PRKAR1A): an update.

Authors:  Anélia Horvath; Jérôme Bertherat; Lionel Groussin; Marine Guillaud-Bataille; Kitman Tsang; Laure Cazabat; Rosella Libé; Elaine Remmers; Fernande René-Corail; Fabio Rueda Faucz; Eric Clauser; Alain Calender; Xavier Bertagna; J Aidan Carney; Constantine A Stratakis
Journal:  Hum Mutat       Date:  2010-04       Impact factor: 4.878

5.  Regulation of protein kinase A activity by p90 ribosomal S6 kinase 1.

Authors:  Xianlong Gao; Tarun B Patel
Journal:  J Biol Chem       Date:  2009-10-05       Impact factor: 5.157

6.  Myxoma of the ear lobe in a 23-month-old girl with Carney complex.

Authors:  George Briassoulis; Martha Quezado; Chyi-Chia Richard Lee; Paraskevi Xekouki; Meg Keil; Constantine A Stratakis
Journal:  J Cutan Pathol       Date:  2011-09-01       Impact factor: 1.587

Review 7.  Ophthalmic eponyms from the Mayo Clinic.

Authors:  G B Bartley
Journal:  Doc Ophthalmol       Date:  1997       Impact factor: 2.379

Review 8.  Carney complex: an update.

Authors:  Ricardo Correa; Paraskevi Salpea; Constantine A Stratakis
Journal:  Eur J Endocrinol       Date:  2015-06-30       Impact factor: 6.664

9.  A transgenic mouse bearing an antisense construct of regulatory subunit type 1A of protein kinase A develops endocrine and other tumours: comparison with Carney complex and other PRKAR1A induced lesions.

Authors:  K J Griffin; L S Kirschner; L Matyakhina; S G Stergiopoulos; A Robinson-White; S M Lenherr; F D Weinberg; E S Claflin; D Batista; I Bourdeau; A Voutetakis; F Sandrini; E M Meoli; A J Bauer; Y S Cho-Chung; S R Bornstein; J A Carney; C A Stratakis
Journal:  J Med Genet       Date:  2004-12       Impact factor: 6.318

10.  Mutations in regulatory subunit type 1A of cyclic adenosine 5'-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes.

Authors:  Jérôme Bertherat; Anélia Horvath; Lionel Groussin; Sophie Grabar; Sosipatros Boikos; Laure Cazabat; Rosella Libe; Fernande René-Corail; Sotirios Stergiopoulos; Isabelle Bourdeau; Thalia Bei; Eric Clauser; Alain Calender; Lawrence S Kirschner; Xavier Bertagna; J Aidan Carney; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2009-03-17       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.